维普期刊资源整合服务平台（V6.5）

149篇 您的检索式：作者名="KILPATRICK ES"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance显示文摘	Jayagopal V Kilpatrick ES Jennings PE	2003	J Clin Endocrinol Metab2003，88，4：	1
2	Biological variation of cysctatin C:implications for the assessment of glomerular filtration rate显示文摘	Keevil BG Kilpatrick ES Nichols SP	1998	Clin Chem1998，44，7：	1
3	Biological variation of cystatin c: omplications for the assessment of glomerular filtration rate显示文摘	Keevil BG Kilpatrick ES Nichols SP	1998	Clin Chem1998，44，9：	1
4	Biological variation of cyslatin C: implications for the assessment of glomerular filtration rate显示文摘	Keevil BG Kilpatrick ES Nichols SP	1998	Clin Chem1998，44，7：	1
5	Biological variation of cystatin C:implication for the assessment of glomerular filtration rate显示文摘	Kilpatrick ES Nichols SP	1998	Clin Chem1998，44，7：	1
6	Arguments for and against the role of glucose variability in the development of diabetes complications显示文摘	Kilpatrick ES		0，，04：	1
7	The biological variation of testosterone and sex hormonebinding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance 显示文摘	Jayagopal V Kilpatrick ES Jennings PE	2003	JClin Endocrinol Metab2003，88，4：	1
8	Biological variation ofcystatin c:implications for the assessment of glomerular filtrationrate显示文摘	Keevil BG Kilpatrick ES Nichols SP	1998	Clin Chem1998，44，7：	1
9	Biological variation of totaltestosterone,free androgen index and bioavailable testosteronein polycystic ovarian syndrome:implications for identifying hyperandrogenaemia显示文摘	Cho LW Kilpatrick ES Jayagopal V	2008	Clin Endocrinol(Oxf)2008，68，3：	1
10	A ward comparison between the One Touch Ⅱand Glucometer Ⅱblood glucose meters显示文摘	Kilpatrick ES McLeod MJ Rumley AG	1994	Diabet Med1994，11，2：	1
11	A comparison be- tween rimonabant and metformin in reducing biochemical hy- perandrogenaemia and insulin resistance in patients with poly- cystic ovary syndrome (PCOS): a randomized open-label paral- lel study显示文摘	Sathyapalan T Cho LI Kilpatrick ES et at	2008	Clin Endocrinol2008，69，6：	1
12	Orfistat is as ben- eficial as mctformin in the treatment of polycystic ovarian syn-drome显示文摘	Jayagopal V Kilpatrick ES Holding S	2005	J Clin Endocrinol Metab2005，90，2：	1
13	Good glyeaemie control: an international perspective on bridging the gap between theory and practice in type 2 diabetes显示文摘	Kilpatrick ES Das AK Orskov C	2008	Current Medical Research and Opinion2008，24，9：	1
14	Niological variation of cystatin C: implication for the assessment of glomerular filtration rate 显示文摘	Keevil GB Kilpatrick ES Nichols SP	1998	Clin Chem1998，44，7：	1
15	Effects of isofla?vone dietary supplementation on cardiovascular risk factors in type 2 diabetes显示文摘	Gonzalez S Jayagopal V Kilpatrick ES et a1	2007	Diabetes Care2007，30，7：	1
16	Metformin maintaius the weight loss and metabolic benefits following rinonabant treatment in obese women with poiystic ovary syndrome 显示文摘	Sathyapalan T Cho L Kilpatrick ES	2005	Clin Endocrinol( oxt)2005，42，7：	1
17	The effect of glucose variability on the risk of microvascular complications in type 1 diabetes显示文摘	Kilpatrick ES Rigby AS Atkin SL	2006	Diabetes Care2006，29，7：	1
18	Impaired fasting glucose andimpaired glucose tolerance:follow-up rates over 2 years within aprimary care setting显示文摘	Ng JM Atkin SL Kilpatrick ES	2010	Diabetes Research2010，31，1：	1
19	Using haemoglobin Ale to diag- nose type 2 diabetes or to identify people at high risk of dia- betes显示文摘	KILPATRICK ES ATKIN SL	2014	BMJ2014，348，25：	1
20	Variability in the relationship between mean plasma glucose and HbAlc:implications for the assessment of glycemic control显示文摘	Kilpatrick ES Rigby AS Atkin SL	2007	Clin Chem May2007，53，5：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示